Catheryn Pasco

Dr. Hermiller serves as Director of the Interventional Cardiology Fellowship, and the Structural Heart Programs at St Vincent Ascension Heart Center in Indianapolis, IN. He is an assistant clinical professor at Duke University. He was recognized as a Master Interventional Cardiologist by the Society of Cardiovascular Angiography and Interventions (SCAI). Dr. Hermiller has expertise in structural heart disease and has been a leading enroller, primary investigator, and steering committee member in many transcatheter therapy studies, including many pivotal trials of coronary and structural heart disease. He has authored or co-authored over 250 published manuscripts. He is past president (2024-2025) of the Society of Cardiac Angiography and Intervention, and his major initiative during his tenure as president was to support advanced radiation protection for operators and staff in the cardiac catheterization laboratory.

A 38 year veteran to the radiology/imaging field; I have been a technologist by trade as well as an operations leader. I have hands-on experience in X-Ray/Fluoro, IR/Angiography, Cath Lab, Mammo, Ultrasound, CT, and MRI. I have lead all areas of radiology department operations as well as involvement in GPO, product evaluation, Qualtiy & Safety, Radiation and MR Safety, process improvement, RCA event team, Patient Access, and developement teams.

Dr. David Rizik completed his undergrad studies in Michigan before attending Saint Louis University Medical School in Saint Louis, Missouri. Internal medicine residency was completed at the Washington University Medical Center. Cardiology and interventional cardiology were completed at William Beaumont Hospital in Detroit. Dr Rizik is board-certified in general and interventional cardiology. He is the Chief Scientific Officer, Director of Structural & Coronary Interventions, and Director of the Interventional Cardiology Fellowship program at HonorHealth. He was principal investigator of the 1st U.S. DES-Trial. He performed and published the first left main bifurcation intervention in the modern DES era. He has been the principal investigator in a number of TAVR, MitraClip and coronary stent trials. A distinguished researcher in interventional cardiology and structural heart disease, he has published more than 100 manuscripts and book chapters. He was awarded the designation Master Interventionalist from the SCAI in 2018. He is founder and organizing Director of the Scottsdale Interventional Forum, a nationally recognized CME meeting. During the COVID pandemic, he was the first to convert a CME meeting to a virtual platform. After a 13 month hiatus of all CME meetings in the US, the Scottsdale Interventional Forum was the first meeting to return to a “live format” publishing the success of this meeting in CCI.
He is executive producer of the two-time Emmy Award winning medical education series “The Procedure”, and executive producer of Scattered Denial, a medical education series highlighting radiation exposure dangers and orthopedic hazards in the cardiac catheterization lab.

Mr. Michael Seymour joined ORSIF in 2015 and served as Director of Advocacy Programs and Managing Author of the ORSIF Economic Study (2017). He is currently a member of ORSIF’s Board of Directors.

With over 45 years of experience in Occupational Health and Safety, Mr. Seymour worked as a consultant and contractor for Federal OSHA since 1979, became an employee in 1999, and retired in 2012. As the first Director of OSHA’s Office of Physical Hazards, he contributed to the development of many OSHA standards, including Ergonomics and Ionizing Radiation. He also served as Director of OSHA’s Office of Technological Feasibility and Acting Deputy Director of OSHA’s Directorate of Standards and Guidance.
Mr. Seymour is active in developing consensus standards for occupational health and safety management. He is a member of the US Delegation for ISO Technical Committee TC-283 (ISO 45001) and the ANSI Z10 Committee. He serves on the Chair’s Advisor Committee for both organizations and as Chairperson of the Small Business Committees for both ANSI Z10 and ISO TC-283.

President, ORSIF
Founder & CMO, Rampart IC

Robert Foster MD is an Interventional cardiologist specializing in peripheral endovascular procedures at The Vein Company in Kingsport TN. He practiced as an IC with Birmingham Heart Clinic, in Birmingham Alabama, for 26 years with special interest in peripheral arterial and venous disease before becoming the Chief Medical Officer for Rampart IC. and the President of ORSIF

Dr. Foster is a graduate of Baylor University and received his medical degree from UAB. After residency at UT Southwestern, he returned to UAB for cardiology fellowship. He then went on staff at UAB as the Clinical Director of Cardiac MRI before joining the Birmingham Heart Clinic.

Dr. Foster’s passion now is creating the safest interventional lab environments to protect physicians and staff from the harmful effects of radiation while reducing orthopedic strain and injury.

Dr Bella Hausen obtained her medical degree from the universities of Manchester and Edinburgh where she was initially a plastic surgical trainee with an interest in micro vascular repair. She completed advance microsurgical training at Zurich, and Rhainoplasty Msc at Barcelona. She went on to complete her Radiology and Interventional Radiology specialist registration with the royal college of Radiology London U.K. She completed her advance Endovascular fellowship with Professor Andrew Holden at Auckland University hospital, NewZealand.

Dr Hausen preformed the first lithotripsy in peripheral endovascular CLI disease, along with the first Sirolimus DCB use in both CLI and AVF, in Europe.

Dr Huasen is the head of endovascular research and innovation in Lancashire U.K. Her current interest are training and education of future doctors, radiation protection for patients and staff, CLI management, AVF salvage, pain management and women’s health. She currently works at Lancashire University health trusts U.K.